March 26, 2025 - 12:16

A team of professors from the Department of Biomedical Engineering at UNIST has introduced an innovative diagnostic technique that promises to revolutionize pathogen identification. This groundbreaking technology boasts an impressive accuracy rate nearing 100% and can deliver results in just three hours.
The method employs artificially designed biosensors that can detect a wide array of pathogens, significantly improving the speed and reliability of diagnostic processes. Traditional diagnostic methods often require longer waiting periods and can be prone to errors, which can delay treatment and exacerbate health issues.
With this new approach, healthcare providers can quickly identify infections and tailor treatment plans more effectively, potentially saving lives and reducing the spread of diseases. The research team believes that this advancement could play a crucial role in managing outbreaks and enhancing public health responses. As the technology advances, it holds the promise of becoming a standard tool in hospitals and clinics worldwide.
June 21, 2026 - 01:52
Mankind must not sacrifice human dignity at the altar of AISome ways of talking about human beings are always out of bounds. Sorting people by economic value into those who merit work and those who should be sidelined is one of them, and any society that...
June 20, 2026 - 18:23
Is Marvell Technology Going to $1 Trillion?Nvidia`s chief executive recently made a bold prediction about Marvell Technology, suggesting the chipmaker could one day join the trillion-dollar club. The comment sparked fresh interest in a...
June 19, 2026 - 18:29
A Tech Twist for Father's Day: New App Brings Old Photos to LifeForget the usual tie or toolbox this Father`s Day. A new mobile application is offering a different kind of gift: the chance to see faded memories with fresh eyes. The app uses simple artificial...
June 19, 2026 - 00:54
FDA panel backs first-of-its-kind flu vaccine using mRNA technologyA new kind of flu vaccine moved a step closer to the U.S. market Thursday. An advisory panel for the Food and Drug Administration voted overwhelmingly in favor of approving the first influenza shot...